Paul Cloos, PhD, is an experienced scientist-entrepreneur and strategic project leader with over 15 years of expertise in life science innovation, drug discovery, and company creation. He has a proven track record in evaluating external assets, leading due diligence efforts, and advancing early-stage R&D projects within biotech and pharmaceutical environments. As a former co-founder of a biotech startup acquired by Gilead, he previously led due diligence and innovation assessment at Novo Holdings Seedlab. His deep cross-functional leadership experience and scientific excellence, evidenced by over 40 publications (including several first authorships in Nature and Cell) and 10+ patent families, enable him to make impactful contributions to partnership management and business development.